Pharmaceuticals
Healthcare
Eight Roads, Anterra Capital invest in Ashish Life Science
Animal pharmaceuticals company Ashish Life Science Pvt. Ltd has raised Rs 45 crore ($6.3 million) in its first external round ......
Healthcare
Online pharmacy NetMeds secures $35 mn from Cambodian business group, others
Online pharmacy NetMeds Marketplace Pvt. Ltd has raised $35 million (Rs 247 crore at current exchange rates) in a Series ......
Healthcare
Drugmaker among others in talks for Series C funding in PharmEasy
Mumbai-headquartered 91 Streets Media Pvt. Ltd, which operates online drug delivery platform PharmEasy, is planning to raise its Series C ......
Healthcare
Torrent Pharma acquires US-based Bio-Pharm
Drugmaker Torrent Pharmaceuticals Ltd has acquired US-based generic pharmaceuticals company Bio-Pharm, Inc. for an undisclosed amount, the company said in ......
Healthcare
Fosun revises offer for Gland Pharma, to acquire smaller stake
China’s Fosun Group has revised its offer to acquire a majority stake in Hyderabad-based Gland Pharma Ltd in a bid ......
Healthcare
Company watch: Concord Biotech eyes new opportunities after Quadria's backing
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology ......
Healthcare
Brinton Pharma raises $4 mn from Tata Capital's healthcare fund
Pune-based drugmaker Brinton Pharmaceuticals Ltd has raised Rs 25.6 crore ($4 million) from Tata Capital Healthcare Fund, the healthcare-focused arm ......
Healthcare
Jubilant Life Sciences explores acquisition of US-based pharma biz
Pharmaceutical and life sciences firm Jubilant Life Sciences Ltd will explore an acquisition of a specialty pharma business in the ......
Healthcare
Sun Pharma's arm to acquire Canadian drug firm Thallion
India's biggest drugmaker Sun Pharmaceutical Industries Ltd has agreed to acquire Canadian pharmaceuticals firm Thallion Pharmaceuticals Inc for 2.7 million ......
Healthcare
Indian drugmakers face squeeze in US on fears of tougher rules
India's small and medium-sized generic drugmakers say the threat of tougher rules and higher barriers for outsiders in the U.S. ......